Back to Results
First PageMeta Content
Drug rehabilitation / Alcohols / Ketones / Substance dependence / Buprenorphine / Drug Addiction Treatment Act / Opioid dependence / Methadone / Naloxone / Chemistry / Organic chemistry / Morphinans


The following letter was sent to Dr. Howard Heit by Patricia M. Good Chief Liaison and Policy Section, Office of Diversion Control an official of the U.S., DEA and therefore should be considered an Official clarification
Add to Reading List

Document Date: 2013-10-29 08:56:01


Open Document

File Size: 56,28 KB

Share Result on Facebook

Country

United States / /

IndustryTerm

buprenorphine products / /

Organization

Center for Substance Abuse Treatment / U.S. Department of Justice / office of Diversion Control / FDA / Drug Enforcement Administration / Policy Section Office / Food and Drug Administration / /

Person

Howard Heit / Patricia M. Good / Liaison / /

Position

physician / Official / official of the U.S. / Chief / /

Product

Subutex / Suboxone / /

SocialTag